Dapagliflozin, a feasible alternative to sulphonylureas as an add-on after metformin failure in type 2 diabetes patients Medha Baranwal24 Jun 2023 11:15 AM ISTKorea: Dapagliflozin is safe and well-tolerated and, therefore, appears to be a more favourable alternative to sulphonylureas as an add-on therapy...
High glycated albumin levels tied to risk of CVD and death in advanced-stage diabetic kidney disease patients Medha Baranwal22 Jun 2023 10:00 AM ISTChina: A meta-analysis published in Diabetes, Obesity and Metabolism has shown an association between high glycated albumin (GA) and an increased risk...
Real-world data reveals remission rate of type 2 diabetes to be 1 in 100 patients Dr. Kamal Kant Kohli16 Jun 2023 10:00 AM ISTJapan: A recent study published in Diabetes, Obesity and Metabolism revealed a greater difference in remission (of type 2 diabetes) incidence and...
Orlistat mouth rinse effectively lowers total and fat calorie intake in obese individuals Jacinthlyn Sylvia23 May 2023 10:00 AM ISTA new study published in the Journal of Diabetes Obesity and Metabolism found that, Orlistat mouth rinse may be an effective alternative in...
Astaxanthin lowers cholesterol and CVD risk in people with prediabetes and dyslipidemia Medha Baranwal6 April 2023 11:30 AM ISTUSA: A recent study published in Diabetes, Obesity and Metabolism has shown that astaxanthin, a natural antioxidant is a safe over-the-counter (OTC)...
Heart failure and CKD raise mortality risk type 2 diabetes patients Medha Baranwal9 March 2023 8:00 PM ISTSingapore: Among patients with new-onset type 2 diabetes mellitus (T2DM), cardiorenal complications are common and are linked with a high risk of...
Canagliflozin use tied to reduced proteinuria in diabetes patients with HF Dr Kartikeya Kohli7 March 2023 9:00 AM ISTJapan: Proteinuria regression with canagliflozin treatment in patients with T2DM (type 2 diabetes mellitus) and chronic heart failure (CHF) is...
Liraglutide reduces ectopic and visceral liver fat in both diabetics and non-diabetics: Study Medha Baranwal6 March 2023 10:30 AM ISTChina: Liraglutide safely and significantly reduces ectopic and visceral liver fact regardless of the absence or presence of type 2 diabetes (T2D), a...
Sotagliflozin effective and safe in reducing HbA1c among diabetes patients with CKD Medha Baranwal18 Feb 2023 10:15 AM ISTUSA: Sotagliflozin 400 but not 200 mg significantly reduced HbA1c compared with placebo after 26 weeks in adults with type 2 diabetes (T2D) and stage...
Exercise-related hypoglycaemia may increase QTc interval in type 1 diabetes patients Dr Kartikeya Kohli24 Jan 2023 11:00 AM ISTDr Per Hagelqvist and team have found in a new study that in people with type 1 diabetes, both hypoglycemia brought on by exercise and hypoglycemia...
Sleep variability linked to blood sugar control in type 2 diabetes patients Dr Kartikeya Kohli24 Dec 2022 7:15 PM ISTChina: A recent study has suggested a link between objectively-determined sleep duration and sleep midpoint and their daily variability with CGM...
Finerenone prevents progression of non-proliferative diabetic retinopathy: Study Medha Baranwal18 Nov 2022 9:15 AM ISTDenmark: A recent study in Diabetes, Obesity and Metabolism has reported the potential benefit of finerenone for delaying the progression of...
